Download presentation
Presentation is loading. Please wait.
Published byAlexa Stewart Modified over 10 years ago
1
The conversion of Saul to St Paul (Michelangelo, 1542) Marcel Leist Doerenkamp-Zbinden Chair For Alternative in vitro Methods, University Konstanz, Konstanz Germany EPAA Annual Conference 2007 Regulatory acceptance and implementation of 3Rs approaches Criteria and Drivers for Acceptance
2
Regulatory acceptance Academia Feedback processes? Developers 3R test pipeline
3
Major drivers for 3R 3R animals confidence Validation Experience Communication Optimised strategies (De)validation
4
Confidence as key factor for regulatory acceptance of alternatives Validation of old AND new methods Safety levels, robustness, assay characteristics,....
5
…also heterogeneity in the design of the available in vivo studies underlies much of the scatter, and this puts a limit on validating in vitro data as predictors of in vivo data. Further analysis of the in vitro-in vivo correlation would therefore require high quality in vivo data, ….. Quantitative extrapolation of in vitro whole embryo culture embryotoxicity data to developmental toxicity in vivo using the Benchmark Dose approach. A.H. Piersma et al, (2007) Toxicol. Sci. Problems with in vivo assays....:
6
…also heterogeneity in the design of the available in vivo studies underlies much of the scatter, and this puts a limit on validating in vitro data as predictors of in vivo data. Further analysis of the in vitro- in vivo correlation would therefore require high quality in vivo data, ….. Quantitative extrapolation of in vitro whole embryo culture embryotoxicity data to developmental toxicity in vivo using the Benchmark Dose approach. A.H. Piersma et al, (2007) Toxicol. Sci. Example:
7
Avoidance of prejudice:....in vitro systems do not predict systemic toxicity......, in vivo systems are better Example: TeGenero TGN1412 The Journal of Immunology (2007), 179, 3325
9
Prejudice: in vitro systems do not predict systemic toxicity
10
The 3R Reduce Replace Refine
11
Driver for regulatory acceptance of reduction Enough is enough - LD50 - Ecotoxicology test strategies - Two-generation studies
12
…study retrospectively evaluates 176 multi-generation studies to assess potential differences between the first and the second generation, both in terms of the types of effects observed and in terms of the effective doses. All substances classified as reproductive toxicants by the Directive 92/32/EEC or considered as toxic to fertility by the California EPA for which we found a multi-generation study were included ….. …The second generation ….. affected neither the overall NOAEL nor the critical effect. Therefore, it had no impact on the ensuing risk assessment, nor on classification and labeling. …. A retrospective analysis of the two-generation study: What is the added value of the second generation ? G. Janers et al, (2007) Reproductive Toxicol. 24, 97
13
…study retrospectively evaluates 176 multi-generation studies to assess potential differences between the first and the second generation, both in terms of the types of effects observed and in terms of the effective doses. All substances classified as reproductive toxicants by the Directive 92/32/EEC or considered as toxic to fertility by the California EPA for which we found a multi-generation study were included ….. …The second generation ….. affected neither the overall NOAEL nor the critical effect. Therefore, it had no impact on the ensuing risk assessment, nor on classification and labeling. …. A retrospective analysis of the two-generation study: What is the added value of the second generation ? G. Janers et al, (2007) Reproductive Toxicol. 24, 97
14
…study retrospectively evaluates 176 multi-generation studies to assess potential differences between the first and the second generation, both in terms of the types of effects observed and in terms of the effective doses. All substances classified as reproductive toxicants by the Directive 92/32/EEC or considered as toxic to fertility by the California EPA for which we found a multi-generation study were included ….. …The second generation ….. affected neither the overall NOAEL nor the critical effect. Therefore, it had no impact on the ensuing risk assessment, nor on classification and labeling. …. A retrospective analysis of the two-generation study: What is the added value of the second generation ? G. Janers et al, (2007) Reproductive Toxicol. 24, 97
15
Method developers Regulators
16
Method developers Regulators Catalyzers/ Facilitators
17
Method developers Regulators Catalyzers/ Facilitators (ECVAM)
18
The validation dilemma: Are we going to hit? Real human safety profile
19
The human safety profile Tuning a test Real human safety profile
20
Any model of human safety Real human safety profile Real world scenarios: - Inexact science - poor human data
21
Accuracy and errors Animal data Human data Real human safety profile Correlations?
22
Accuracy and errors Real human safety profile Correlations? False positive False negative Accurate
23
Animal models of human safety Animal data Real human safety profile
24
Real world scenarios! Correlation of models of human safety Animal data Real human safety profile Alternative data
25
Real world scenarios! Correlation of models of human safety Animal data Real human safety profile Alternative data
26
Comparison to in vitro data Model correlation Real human safety profile Examples from ECVAM/NICEATM study corr. = 0.53 correlation = 0.56 correlation = 0.62 Personal communication T. Hartung; n = 45
27
One step further.................. Coverage of complex toxicity by integrated test batteries (e.g developmental toxicity)
28
Integrated test batteries Real human safety profile Reproductive toxicity spermatogenesis 2-Generation study
29
Integrated test batteries Real human safety profile
30
Validation procedure and regulatory acceptance Early collaboration/contact of producer (test developer) and customer (regulator) Agreement on relevant reference points - Gold standard - Reference data base - Reference compound base - State of the art of method and competitors - Situation in other sectors and countries
31
- Buildup of experience how to interpret data; how to deal with data, historic feedback Biological system Exposure situation Model endpoint Prediction model Test Validated Test Applied Test Regulator input: tuning Regulator input: fine-tuning/post-validation - Continuous feedback in test pipeline Validation procedure and regulatory acceptance
32
University Konstanz Doerenkamp-Zbinden Foundation
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.